Observational study / 2012
Six cases of lead poisoning in pregnant women in NYC were linked to the use of oral Ayurvedic medications made in India.
During 2011-2012, the New York City Department of Health and Mental Hygiene investigated six cases of lead poisoning linked to 10 oral Ayurvedic medications manufactured in India. All cases occurred in foreign-born pregnant women whose blood lead levels ranged from 16 to 64 µg/dL. The tested medications contained lead concentrations as high as 2.4%, with several also containing mercury or arsenic. Officials ordered a local business to cease sales and distributed warnings to providers, manufacturers, and agencies.
Shows an association, not proof of cause and effect.
- Study type
- Case series investigation
- Who was studied
- 6 foreign-born pregnant women in New York City
- What was measured
- Blood lead levels and heavy metal concentrations in oral Ayurvedic medications
THE PAPER
Lead poisoning in pregnant women who used Ayurvedic medications from India--New York City, 2011-2012.
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.